Blockchain Registration Transaction Record

LabConnect Appoints Industry Veteran Bill Finger as SVP of Global Strategic Services

LabConnect appoints Bill Finger as SVP of Global Strategic Services, bringing 25+ years of diagnostics experience to enhance central laboratory services for complex clinical trials.

This appointment matters because LabConnect plays a critical role in supporting complex clinical trials for groundbreaking treatments including immuno-oncology, cell and gene therapies, and rare diseases. The hiring of an experienced executive like Bill Finger signals the company's commitment to enhancing its capabilities in an increasingly complex clinical research landscape. For patients awaiting new treatments and for pharmaceutical companies developing innovative therapies, strong laboratory partners like LabConnect are essential for ensuring accurate data collection, regulatory compliance, and ultimately, bringing safe and effective treatments to market faster. Finger's extensive background with major diagnostic companies suggests LabConnect is positioning itself to handle the growing complexity of modern clinical trials, which could accelerate the development of life-saving therapies.